Upload Avatar (500 x 500)
余潇
xiaoyu523@smu.edu.cn
英语, 中文
广东
南方医科大学
Basic Medical Sciences
  • 2023年: 获聘教育部国家级人才项目青年学者
  • 2024年: 获第十二届中国免疫学会学术奖青年学者奖
  • 2019年: 获聘广东省“青年珠江学者”
固有免疫系统识别和调控机制与感染性疾病相关性研究
  • The Toxoplasma Effector GRA4 Hijacks Host TBK1 to Oppositely Regulate Anti-T. Gondii Immunity and Tumor Immunotherapy, Hu Z., Zhang Y., Xie Y., Yang J., Tang H., Fan B., Zeng K., Han Z., Lu J., Jiang H., Peng W., Li H., Chen H., Wu S., Shen B., Lun Z.R., and Yu X., 2024
  • Dual nature of type I interferon responses and feedback regulations by SOCS1 dictate malaria mortality, Lu J., Hu Z., Jiang H., Wen Z., Li H., Li J., Zeng K., Xie Y., Chen H., Su X.Z., Cai C., and Yu X., 2024
  • Pristimerin suppresses AIM2 inflammasome by modulating AIM2-PYCARD/ASC stability via selective autophagy to alleviate tendinopathy, Jiang H., Xie Y., Lu J., Li H., Zeng K., Hu Z., Wu D., Yang J., Yao Z., Chen H., Gong X., and Yu X., 2024
  • VANGL2 inhibits antiviral IFN-I signaling by targeting TBK1 for autophagic degradation, Hu Z., Xie Y., Lu J., Yang J., Zhang J., Jiang H., Li H., Zhang Y., Wu D., Zeng K., Bai X., and Yu X., 2023
  • Natural killer cells: Warriors against malaria, Li H. and Yu X., 2023
  • Vangl2 suppresses NF-kB signaling and ameliorates sepsis by targeting p65 for NDP52-mediated autophagic degradation, Lu J., Zhang J., Jiang H., Hu Z., He L., Yang J., Xie Y., Wu D., Li H., Zeng K., Tan P., Xiao Q., Song Z., Bai X., and Yu X., 2023
  • SHIP1 modulates antimalarial immunity by bridging the crosstalk between type I IFN signaling and autophagy, Li H., Yang S., Zeng K., Guo J., Wu J., Jiang H., Xie Y., Lu J., Hu Z., Yang J., Su X., Cui J., and Yu X., 2023
  • Function and regulation of cGAS-STING signaling in infectious diseases, Du Y., Hu Z., Luo Y., Wang H.Y., Yu X., and Wang R.F., 2023
  • Activation of cGAS-STING by Lethal Malaria N67C Dictates Immunity and Mortality through Induction of CD11b(+) Ly6C(hi) Proinflammatory Monocytes, Du Y., Luo Y., Hu Z., Lu J., Liu X., Xing C., Wu J., Duan T., Chu J., Wang H.Y., Su X.Z., Yu X., and Wang R.F., 2022
  • Inflammasome Activation Dampens Type I IFN Signaling to Strengthen Anti-Toxoplasma Immunity, Hu Z., Wu D., Lu J., Zhang Y., Yu S.M., Xie Y., Li H., Yang J., Lai D.H., Zeng K., Jiang H., Lun Z.R., and Yu X., 2022
  • Friedelin Alleviates the Pathogenesis of Collagenase-Induced Tendinopathy in Mice by Promoting the Selective Autophagic Degradation of p65, Jiang H., Lin X., Liang W., Li Y., and Yu X., 2022
  • Pseudolaric acid B ameliorates synovial inflammation and vessel formation by stabilizing PPARgamma to inhibit NF-kappaB signalling pathway, Lu J., Guan H., Wu D., Hu Z., Zhang H., Jiang H., Yu J., Zeng K., Li H., Zhang H., Pan C., Cai D., and Yu X., 2021
  • Accelerator or Brake: Immune Regulators in Malaria, Cai C., Hu Z., and Yu X., 2020
  • A mathematic model to reveal delicate cross-regulation between MAVS/STING, inflammasome and MyD88-dependent type I interferon signalling, Cai C. and Yu X., 2020
  • Inflammasome activation negatively regulates MyD88-IRF7 type I IFN signaling and anti-malaria immunity, Yu X., Du Y., Cai C., Cai B., Zhu M., Xing C., Tan P., Lin M., Wu J., Li J., Wang M., Wang H.Y., Su X.Z., and Wang R.F., 2018
  • A novel miR-200b-3p/p38IP pair regulates monocyte/macrophage differentiation, Yu X., Wang Q.L., Li Y.F., Wang X.D., Xu A., and Li Y., 2016
  • Cross-Regulation of Two Type I Interferon Signaling Pathways in Plasmacytoid Dendritic Cells Controls Anti-malaria Immunity and Host Mortality, Yu X., Cai B., Wang M., Tan P., Ding X., Wu J., Li J., Li Q., Liu P., Xing C., Wang H.Y., Su X.Z., and Wang R.F., 2016
感染 免疫 固有免疫 I型干扰素 炎症小体 调控 机制 宿主反应 免疫稳态 治疗靶点

联系我们

欢迎与我们交流!
* Required
* Required
* Required
* Invalid email address
提交此表单,即表示您同意 IoT ONE 可以与您联系并分享洞察和营销信息。
不,谢谢,我不想收到来自 IoT ONE 的任何营销电子邮件。
提交

感谢您的信息!
我们会很快与你取得联系。